Summary by Moomoo AI
PIONEERING PHARMACEUTICAL-B (09939.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 5, 2024, REPORTING THE CHANGES IN COMPANY SHARES FOR THE YEAR ENDED MARCH 31, 2024. The report shows that the company's regulated/registered share capital has not changed in the past month, with 700,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0001 per share, and the total regulated/registered share capital remained at $70,000. In addition, the report confirms that the securities issued by the company this month have been formally authorized by the Board of Directors and have met all pre-listing regulatory requirements. Discovery Pharmaceuticals-B is a limited company incorporated in the Cayman Islands and presented this report by the Chairman, Executive Director and Chief Executive Officer, Tofu Yui.